Cited by CrossRef (6)
- Shih-Hsiang Chen, Jiann-Shiuh Chen, Shiann-Tarng Jou, Kang-Hsi Wu, Iou-Jih Hung, Jiunn-Ming Sheen, Meng-Yao Lu, Bow-Wen Chen, Tang-Her Jaing, Shih-Chung Wang, Ming-Tsan Lin, Te-Kau Chang, Hsi-Che Liu, Chao-Ping Yang. Outcome and prognosis of anaplastic large cell lymphoma in children: a report from the Taiwan Pediatric Oncology Group. Leukemia & Lymphoma 2019;60:1942
- Yu-Tong Zhang, Li-Zhe Wang, Jian Chang. Characteristics and Outcomes of Chinese Children With Advanced Stage Anaplastic Large Cell Lymphoma: A Single-Center Experience. Front. Oncol. 2022;12
- Eric J. Lowe, Laurence Brugieres. Non-Hodgkin's Lymphoma in Childhood and Adolescence. 2022.
- A. S. Volkova, T. T. Valiev, N. A. Batmanova, S. A. Yuldasheva, Z. S. Gordeeva, S. L. Sabantsev, G. A. Aleskerova, I. V. Osipova, S. R. Varfolomeeva. ALCL Protocol of the DOIG Research Institute 2003: results of treatment of anaplastic large cell lymphoma in children in a comparative multicenter clinical trial. Gematologiâ i transfuziologiâ 2023;68:432
- Ling Huang, Fen Zhang, Jialong Zeng, Hanguo Guo, Sichu Liu, Xiaojuan Wei, Feili Chen, Xinmiao Jiang, Zhanli Liang, Yanhui Liu, Wenyu Li. ALK expression plays different roles in anaplastic large-cell lymphomas and outcome of crizotinib use in relapsed/refractory ALK+ patients in a Chinese population. Ann Hematol 2018;97:149
- Changfei Qin, Yuhua Huang, Yanfen Feng, Min Li, Na Guo, Huilan Rao. Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases. Diagn Pathol 2018;13